A.I. is Changing the Drug Discovery and Lantern is Leading the Charge
Panna Sharma, CEO, Lantern Pharma Life-saving drugs are a cornerstone of modern medicine, developed by pharmaceutical companies over years of research to cure and prevent diseases. But what if this process could be faster and more affordable? Thanks to artificial intelligence (A.I.), that’s now becoming a reality. Pharmaceutical companies, like Lantern Pharma are leveraging A.I. to boost efficiency and profitability. Traditionally, drug development is costly and time-consuming—often requiring billions of dollars and years of trials with no guarantee of success. A.I. is changing that, helping companies discover and develop new medicines more quickly and effectively.
A.I. is Changing the Drug Discovery and Lantern is Leading the Charge
